Sarah Carmody | Executive Director-Investor Relations and Corporate Communications |
Anna Protopapas | President and Chief Executive Officer |
Dirk Huebner | Chief Medical Officer |
Tim Lowinger | Chief Science and Technology Officer |
Brian DeSchuytner | Senior Vice President-Finance and Product Strategy |
Eva Jack | Chief Business Officer |
Jonathan Chang | SVB Leerink |
Earl DeSouza | H.C. Wainwright |
Boris Peaker | Cowen |
Tom Shrader | BTIG |
Jessica Fye | J.P. Morgan |
Mike Ulz | Baird |
David Nierengarten | Wedbush Securities |
Ladies and gentlemen, thank you for standing by, and welcome to the Mersana First Quarter 2020 Earnings Conference Call. At this time, all participants’ lines are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]